the aid library

LIST OPTIONS

Filter

6010

Download (130)

View PDF (274)

Commonly abused drugs and withdrawal symptoms

National Institute on Drug Abuse (2019) C2

Accessed: 22.03.2019

Download (231)

View PDF (290)

Cross-Cultural Variance of Schizophrenia in Symptoms, Diagnosis and Treatment

Banerjee, A. (2012) C2

The Georgetown Undergraduate Journal of Health Services (2), 2012.

External Link

Association between HIV status and depressive symptoms among children and adolescents in the Southern Highlands Zone, Tanzania: A case-control study

A. Lwidiko; S. M. Kibusi; A. Nyundo; et al. PLOS One (2018) CC

PLOS ONE | https://doi.org/10.1371/journal.pone.0193145 February 22, 2018 1 / 13

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19
recommended

World Health Organization WHO; Regional Office for Africa (2020) C_WHO

Risk Communication and Community Engagement messages

External Link

What is Dengue? Causes, Signs and Symptoms, Diagnosis and treatment.

Medical Centric Medical Centric (2018) CC

Chapters 0:00 Introduction 0.27 Causes of Dengue Fever 1:09 Signs and Symptoms of Dengue Fever 2:30 Dengue Hemorrhagic Fever 3:53 Diagnosis of Dengue Fever 4:10 Treatment of Dengue Fever Dengue fever is a mosquito-borne tropical disease caused by the dengue virus. Symptoms typically beg... more

External Link

Buruli ulcer (Mycobacterium ulcerans infection) - symptoms and treatment

World Health Organization WHO (2023) C_WHO

Website - last accessed on 18.03.2023

Type 1 Daibetes - The big 3 Symptoms

Diabetes.co.uk. the global diabetes community (2024) CC2

Type 1 Daibetes - The big 3 Symptoms - Poster experiencing these symptoms? see a doctor

Worldwide trends in the burden of asthma symptoms in school-aged children: Global Asthma Network Phase I cross-sectional study

Asher, I.; Rutter, C.E.; Bissell, K. et al. The Lancet (2021) CC

Asthma is the most common chronic disease in children globally. The Global Asthma Network (GAN) Phase I study aimed to determine if the worldwide burden of asthma symptoms is changing. This updated cross-sectional study used the same methods as the International study of Asthma and Allergies in Chi...ldhood (ISAAC) Phase III. Asthma symptoms were assessed from centres that completed GAN Phase I and ISAAC Phase I (1993–95), ISAAC Phase III (2001–03), or both. We included individuals from two age groups (children aged 6–7 years and adolescents aged 13–14 years) who self-completed written questionnaires at school. We estimated the 10-year rate of change in prevalence of current wheeze, severe asthma symptoms, ever having asthma, exercise wheeze, and night cough (defined by core questions in the questionnaire) for each centre, and we estimated trends across world regions and income levels using mixed-effects linear regression models with region and country income level as confounders. Overall, 119 795 participants from 27 centres in 14 countries were included: 74 361 adolescents (response rate 90%) and 45 434 children (response rate 79%). About one in ten individuals of both age groups had wheeze in the preceding year, of whom almost half had severe symptoms. Most centres showed a change in prevalence of 2 SE or more between ISAAC Phase III to GAN Phase I. Over the 27-year period (1993–2020), adolescents showed a significant decrease in percentage point prevalence per decade in severe asthma symptoms (–0·37, 95% CI –0·69 to –0·04) and an increase in ever having asthma (1·25, 0·67 to 1·83) and night cough (4·25, 3·06 to 5·44), which was also found in children (3·21, 1·80 to 4·62). The prevalence of current wheeze decreased in low-income countries (–1·37, –2·47 to –0·27], in children and –1·67, –2·70 to –0·64, in adolescents) and increased in lower-middle-income countries (1·99, 0·33 to 3·66, in children and 1·69, 0·13 to 3·25, in adolescents), but it was stable in upper-middle-income and high-income countries. Trends in prevalence and severity of asthma symptoms over the past three decades varied by age group, country income, region, and centre. The high worldwide burden of severe asthma symptoms would be mitigated by enabling access to effective therapies for asthma. more

Household biomass fuel use, asthma symptoms severity, and asthma underdiagnosis in rural schoolchildren in Nigeria: a cross-sectional observational study

Oluwole, O.; Arinola, G.O.; Hou, D.; Olopade, C.O. (2017) CC2

In 2014, the International Study of Asthma and Allergies in Childhood (ISAAC) reported that the highest prevalence of symptoms of severe asthma was found in the low- and middle-income countries (LMICs), including Nigeria. While exposure to biomass fuel use may be an important risk factor in the deve... more

10 Things you can do to manage your Covid-19 Symptoms at Home (Kreyol aysiyen)

Centers for Disease Control and Prevention CDC (2021) C_CDC

10 BAGAY OU K A FÈ POU JERE SENTÒM COVID-19 OU YO L AK AY OU

Download (137)

View PDF (184)

COVID-19 in Latin America and the caribbean region: Symptoms and morbidities in the epidemiology of infection

Anaya-Covarrubias, J.Y.; et al. (2022) C1

Curr Opin Pharmacol . 2022 Apr;63:102203.doi: 10.1016/j.coph.2022.102203. Epub 2022 Feb 11. The COVID-19 pandemic has widespread economic and social effects on Latin America (LA) and the Caribbean (CA). This region, which has a high prevalence of chronic diseases, has been one of the most affected... more

Diabetes Poster - Do you have any of these symptoms?

Diabetes.co.uk. the global diabetes community (2024) CC2

Diabetes Poster - Do you have any of these symptoms?

Diabetes Poster - Does your child show any of these symptoms?

Drugs for Neglected Diseases initiative DNDi (2024) CC2

Diabetes Poster - Does your child show any of these symptoms?

External Link

Interim Recommendations for Cleaning Houses Safely in West Africa Ebola-Affected Areas after Persons with Symptoms of Ebola are Transferred to Ebola Treatment Units or Community Care Centers

Centers for Disease Control and Prevention CDC (2014)

Download (177)

View PDF (210)

COVID-19 clinical care pathway (‎CARE)‎: confirm SARS-CoV-2 infection, assess symptoms, risk factors and severity, respond with appropriate care and treatment, evaluate clinical response and recovery

World Health Organization WHO (2022) CC

The COVID-19 CARE pathway is a living tool to support health care workers visualize the current clinical and therapeutic recommendations to be considered in the care planning for patients with COVID-19. The COVID-19 CARE pathway is aligned with the eighth version of the WHO Therapeutics and COVID... more

Providing access to clean water and sharing critical information on the causes, symptoms, and prevention of cholera (Arabic)

UN Children's Fund UNICEF (2022) C_UNICEF

24 October 2022

Corona Virus Desease - What you need to know

International SOS (2020) C2

Transmission Symptoms Prevention Treatment

External Link

Science in 5 Episode #22 - Children & COVID-19

World Health Organization WHO (2021) CC

Are the symptoms of COVID-19 different in children? Do the new variants impact children differently? What can parents do to keep children safe from COVID-19. WHO's Dr Maria Van Kerkhove explains in Science in 5. Science in 5 is WHO’s conversations in science. Watch WHO experts explain science... more

External Link

WHO Science in 5: Episode #73 - Monkeypox

World Health Organization WHO (2022) C_WHO

What are the symptoms of monkeypox? Who is at risk and how can we protect ourselves? Why is WHO concerned about it? WHO’s Dr Rosamund Lewis explains in Science in 5.

Download (122)

View PDF (156)

أعراض الكوليرا

UN Children's Fund UNICEF (2022) C_UNICEF

Poster Cholera Symptoms

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19 recommended

Asymptomatic, Pre-symptomatic and Mild Signs and Symptoms of COVID-19
recommended